Order Article Reprints

Confino H, Sela Y, Epshtein Y, Malka L, Goldshtein M, Chaisson S, Lisi S, Avniel A, Monson JM, Dirbas FM. Intratumoral Administration of High-Concentration Nitric Oxide and Anti-mPD-1 Treatment Improves Tumor Regression Rates and Survival in CT26 Tumor-Bearing Mice. Cells. 2023; 12(20):2439. https://doi.org/10.3390/cells12202439

Confino, Hila, Yogev Sela, Yana Epshtein, Lidor Malka, Matan Goldshtein, Selena Chaisson, Steve Lisi, Amir Avniel, Jedidiah Mercer Monson, and Frederick M. Dirbas. 2023. "Intratumoral Administration of High-Concentration Nitric Oxide and Anti-mPD-1 Treatment Improves Tumor Regression Rates and Survival in CT26 Tumor-Bearing Mice" Cells 12, no. 20: 2439. https://doi.org/10.3390/cells12202439

Confino, H., Sela, Y., Epshtein, Y., Malka, L., Goldshtein, M., Chaisson, S., Lisi, S., Avniel, A., Monson, J. M., & Dirbas, F. M. (2023). Intratumoral Administration of High-Concentration Nitric Oxide and Anti-mPD-1 Treatment Improves Tumor Regression Rates and Survival in CT26 Tumor-Bearing Mice. Cells, 12(20), 2439. https://doi.org/10.3390/cells12202439